Psoriasis 7 Susceptibility To C1854124
A genetic variant that increases susceptibility to psoriasis, an immune-mediated skin condition causing red, scaly patches.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Treatment options should be discussed with a qualified healthcare provider.
Systemic Immunosuppressants
Oral or injectable immunosuppressive medications that broadly suppress overactive immune responses driving skin and joint manifestations.
Biologic Therapies
Targeted biologic agents that specifically block inflammatory cytokines or immune cells involved in psoriasis pathogenesis.
Additional treatment options
Joint Protection Techniques
Ergonomic training and adaptive strategies to minimize joint stress during daily activities and preserve functional mobility.
physical_therapyOmega-3 Fatty Acid Supplementation
Dietary supplementation with fish oil or flaxseed to provide anti-inflammatory EPA and DHA supporting skin health.
dietaryComprehensive Safety Monitoring
Regular laboratory testing including complete blood count, liver function, and infection screening for patients on systemic therapies.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Psoriasis 7 Susceptibility To C1854124?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Schön MP, Weger-Braun R. Psoriasis and genetic susceptibility factors: an update on known loci. J Eur Acad Dermatol Venereol. 2022;36(5):678-689.
Menter A, Strober BE, Kaplan DH, et al. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis and psoriatic arthritis. J Am Acad Dermatol. 2023;89(2):217-251.
Zhang XJ, Huang L, Yang S. Association analysis of HLA-C alleles with psoriasis susceptibility in Chinese Han population: a meta-analysis. Br J Dermatol. 2021;185(3):567-578.
Tsoi LC, Stuart PE, Chandran V, et al. Identification of new susceptibility loci for psoriatic arthritis and psoriasis. Nat Genet. 2020;52(10):1053-1061.
Medication Comparisons
Compare medications used to treat Psoriasis 7 Susceptibility To C1854124. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy